sirs
Latest round
- Seed
Last raised
- Jan 2022
Total raised
- Undisclosed
Investors
- 1
About sirs
Founded in 2021 and based in Seoul, South Korea, sirs inc. is a company that operates medical healthcare platform services for men. In January 2022, sirs inc. The company operates sirs, a non-face-to-face medication prescribing service that provides a question-and-answer service for Stigmatized Health Disease and SHD-related medical or pharmaceutical consultation, and is also researching and developing functional food. SHD refers to diseases that are uncomfortable to receive treatment or prescriptions, such as hair loss, sexual function, obesity, and depression. The company's platform allows users to apply for medical treatment, get a prescription and get treatment over the phone, and also can get medicines delivered to their homes.
Who invested in sirs
1 investor across 1 round
See all investors in sirs
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 11, 2022
Amount
Undisclosed
Investors
Questions about sirs
Who invested in sirs?
sirs has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has sirs raised?
sirs has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did sirs last raise money?
sirs's most recent round on record is a Seed, in Jan 2022.
What does sirs do?
Founded in 2021 and based in Seoul, South Korea, sirs inc.
Where is sirs headquartered?
sirs is headquartered in Seoul, South Korea.
Which VCs invest in companies like sirs?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back healthcare it companies at sirs's stage. Their profiles are linked below.
VCs backing healthcare it startups at Seed
Raising like sirs? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.